American Vanguard (NYSE:AVD) Announces Quarterly Earnings Results

American Vanguard (NYSE:AVD) issued its earnings results on Monday. The basic materials company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.10), Zacks reports. American Vanguard had a negative return on equity of 26.21% and a negative net margin of 23.72%.

American Vanguard Stock Performance

AVD stock opened at $5.06 on Tuesday. The company has a 50-day simple moving average of $5.30 and a 200 day simple moving average of $4.67. The company has a market capitalization of $143.86 million, a P/E ratio of -1.13 and a beta of 1.26. The company has a quick ratio of 1.00, a current ratio of 1.91 and a debt-to-equity ratio of 0.82. American Vanguard has a fifty-two week low of $3.28 and a fifty-two week high of $6.68.

Hedge Funds Weigh In On American Vanguard

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Strs Ohio bought a new position in shares of American Vanguard during the first quarter valued at $28,000. Geode Capital Management LLC lifted its holdings in American Vanguard by 2.2% during the 2nd quarter. Geode Capital Management LLC now owns 639,301 shares of the basic materials company’s stock valued at $2,506,000 after purchasing an additional 13,657 shares during the last quarter. XTX Topco Ltd acquired a new position in American Vanguard in the second quarter valued at about $57,000. Ameriprise Financial Inc. boosted its position in American Vanguard by 18.7% in the second quarter. Ameriprise Financial Inc. now owns 190,223 shares of the basic materials company’s stock valued at $746,000 after buying an additional 29,942 shares in the last quarter. Finally, Jane Street Group LLC grew its stake in American Vanguard by 287.6% during the first quarter. Jane Street Group LLC now owns 40,509 shares of the basic materials company’s stock worth $178,000 after buying an additional 30,058 shares during the last quarter. 79.00% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of American Vanguard in a research note on Wednesday, October 8th. Wall Street Zen upgraded shares of American Vanguard from a “hold” rating to a “buy” rating in a research note on Friday, September 5th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $12.00.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.